ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 1267

Are Anti-SRP Auto-Antibodies Specific for Myositis?

Samantha Rodriguez-Muguruza1, Ines Lozano2, Jaume Coll3, Maria Lourdes Mateo1, Susana Holgado1, Eva Martínez-Cácerez2 and Alejandro Olivé Marqués1, 1Rheumatology, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain, 2Immunology, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain, 3Neurology, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Autoantibodies and myositis

  • Tweet
  • Email
  • Print
Session Information

Session Title: Muscle Biology, Myositis and Myopathies: Myositis Autoantibodies and Disease Phenotype

Session Type: Abstract Submissions (ACR)

Background/Purpose . Myositis-specific auto-antibodies (Ab) include those directed against aminoacyl-tRNA synthetases (ARS), signal recognition particle (SRP) and nuclear helicase Mi-2. Anti-SRP Ab are among the most abundant and best characterized myositis-specific Ab. Patients diagnosed with myositis associated with anti-SRP Ab are mainly associated with aggressive disease and poor prognosis and are refractory to glucocorticoids / To determine the clinical features, serological features and long-term prognosis among patients with anti-SRP Ab.

Methods . We retrospectively analyzed 8 patients with positive anti-SRP Ab, detected between 2000 and 2013 in our hospital (Tertiary, referral: 850,000 inhabitants). Medical records of patients with polymyositis (PM) or dermatomyositis according to the Bohan and Peter criteria, and patients with anti-cytoplasmic Ab, were reviewed regardless of diagnosis. Past and current status were assessed from hospital records. A post-questionnaire, personal interview and electromyography (EMG) test were performed in patients without myositis. Anti-nuclear Ab and anti-tissue Ab (AMA, LC, LKM) were tested at diagnosis by indirect immunofluorescence on Hep-2000 cells (Immunoconcepts®) and in-house tissue, respectively. Myositis-specific Ab: anti-ARS (Jo-1, PL7, PL12) and anti-SRP were tested by immunoblot (Orgentec®). In addition, levels of creatine kinase (CK) were measured by turbidimetry (Roche®)

Results . Patients with anti-SRP Ab were 6 Caucasians and 2 north-African women, mean age 63 years; three (37.5%) had PM (1 associated with systemic sclerosis). At diagnosis, muscle weakness was severe in 2 patients (defined as < 3 of manual muscle strength testing), associated with dysphagia and respiratory muscle involvement. Season of onset of muscle weakness: 2 in spring and 1 in winter. All 3 patients were treated with glucocorticoids; 2 required immunosuppressive agents (methotrexate, azathioprine, rituximab or intravenous immunoglobulin). Histological study of biceps brachii showed histological changes consistent with necrotising myopathy with scarce inflammatory cells. Five (62.5%) patients showed no features of myositis after a follow-up of 6 months to 3.5 years; 4 had a normal EMG and normal CK levels. Their diagnoses were: rheumatoid arthritis, Sjögren´s syndrome, autoimmune hepatitis, and primary biliary cirrhosis (pure and associated with systemic sclerosis). There were no deaths or history of malignancy among the 8 anti-SRP patients. 

Race/Age (years)

Diagnosis

Treatment

EMG

CK U/L                       (maximum)

Other Ab

North african/36

Autoimmune hepatitis

Azathioprine

N/A

40

Ro52, La

White/65

Primary biliary cirrhosis, sarcoidosis

 Ursobilane

Normal

42

 M2

White/69

Primary biliary cirrhosis, systemic sclerosis

Ursobilane

Normal

72

M2, Cep B

White/83

Rheumatoid arthritis

Azathioprine, prednisone

Normal

37

Anti-CCP antibodies , ANA Homogenous Pattern 1/640

White/74

Sjogren´s Syndrome

No

Normal

41

Ro 52, Ro 60, La

North african/46

PM

Methotrexate, azathioprine, prednisone, Ig, Rituximab

polymyositis

3000

Ro 52, La

White/80

PM

Methotrexate, prednisone

polymyositis

2339

No

White/58

PM, systemic sclerosis

Prednisone

polymyositis

1100

Ro52, SP100

N/A  not available.

Conclusion . Although anti-SRP remains a specific Ab for PM, it is occasionally detected in patients with other rheumatic diseases and autoimmune hepatitis in the absence of myositis.


Disclosure:

S. Rodriguez-Muguruza,
None;

I. Lozano,
None;

J. Coll,
None;

M. L. Mateo,
None;

S. Holgado,
None;

E. Martínez-Cácerez,
None;

A. Olivé Marqués,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/are-anti-srp-auto-antibodies-specific-for-myositis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2022 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies